LncRNA TUG1 Knockdown Reduces Cardiomyocyte Damage in Viral Myocarditis by Targeting the miR-140-3p/CXCL8 Axis. [PDF]
Shi J, Sun Q.
europepmc +1 more source
Altered colonic microflora and its metabolic profile in mice with acute viral myocarditis induced by coxsackievirus B3. [PDF]
Xue Y +7 more
europepmc +1 more source
New algorithms for the diagnosis and management of post-viral infection myocarditis
Felipe Sampaio +3 more
openalex +2 more sources
Viral myocarditis in combination with genetic cardiomyopathy as a cause of sudden death. An autopsy series. [PDF]
Callon D +5 more
europepmc +1 more source
Authors' response to: How to manage ventricular arrhythmia in patients with viral myocarditis. [PDF]
Villatore A, Peretto G.
europepmc +1 more source
How to manage ventricular arrhythmia in patients with viral myocarditis. [PDF]
Kataoka N, Imamura T.
europepmc +1 more source
Related searches:
Viral Myocarditis-Incidence, Diagnosis and Management.
Journal of Cardiothoracic and Vascular Anesthesia, 2020Viral myocarditis has an incidence rate of 10 to 22 per 100,000 individuals. The presentation pattern of viral myocarditis can range from nonspecific symptoms of fatigue and shortness of breath to more aggressive symptoms that mimic acute coronary ...
M. Olejniczak +4 more
semanticscholar +1 more source
Multitargeted Immunomodulatory Therapy for Viral Myocarditis by Engineered Extracellular Vesicles.
ACS NanoImmune regulation therapies are considered promising for treating classically activated macrophage (M1)-driven viral myocarditis (VM). Alternatively, activated macrophage (M2)-derived extracellular vesicles (M2 EVs) have great immunomodulatory potential ...
W. Pei +6 more
semanticscholar +1 more source
In recent years, more young patients are being admitted to hospitals with the diagnosis of heart failure secondary to myocarditis; many of these patients will progress to needing a heart transplant.
Oksana Narovlyanskaya +1 more
semanticscholar +1 more source

